Swiss HLG Afterwork: Carve Outs in Pharma and Beyond
Share this event
The Swiss HLG Afterwork, Carve Outs in Pharma and Beyond, is taking place on 1 October 2026 at Campus Biotech In Geneva
Be part of an insightful evening co‑hosted by Swiss HLG and Gyrus Capital to explore one of the most powerful value creation strategies in healthcare and life sciences: carve-outs.
By separating non-core assets or businesses into independent companies, carve-outs can unlock hidden value, sharpen strategic focus, and create platforms for sustainable growth.
🎤 Keynote Speaker:
Etienne Jornod: Executive Chairman of OM Pharma, Former Executive Chairman Galenica and Vifor, Former Chairman NZZ and Director Alliance Boots (KKR), will share insights from the successful spin‑out of OM Pharma from Vifor and the lessons learned from this transformative transaction.
💡 Market and Strategic Insights:
Elsa Torchet: Director, Life Sciences, Strategy and Business Design, Deloitte
Igor Heinzer: Partner – Head of Valuation and Modelling, Deloitte
💼 Investor and Operational Insights:
Anna Mattsson: Senior Partner at McKinsey & Company
Becki Morison: CEO, Essential Pharma
Robert Watson: Co-founder, Gyrus Capital
📅 1 October 2026 |📍 Campus Biotech, Geneva | ➡️ Register